Clinical Trials

Phase 1/2 Active not recruiting

Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT04542824 2026-03-03

EPCORE™ NHL-3

78 enrolled

Phase 2 Not yet recruiting

Lymphoma, Follicular, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Large B-Cell, Diffuse, Lymphoma, B-Cell, Marginal Zone

NCT07029776 2026-03-03

MMulti-Immune HR; Multi-Target Immunotherapy for High-Risk Multiple Myeloma

50 enrolled

Phase 3 Not yet recruiting

Multiple Myeloma

NCT07407140 2026-03-02

VAG-3+7-G

300 enrolled

Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT06587451 2026-02-24

Integrated Pharmacokinetics (PK)/Efficacy, Safety, and Immunogenicity Study to Demonstrate Similarity of JPB898, a Proposed Biosimilar to Nivolumab, to Opdivo® in Combination With Yervoy®

Phase 3 Terminated

52 enrolled

Dermatologic

Melanoma

NCT07405736 2026-02-12

Lubiprostone Combined With Maintenance Therapy for Prevention of Postoperative Recurrence in Peritoneal Metastatic Colorectal Cancer

Phase 2 Not yet recruiting

124 enrolled

Gastrointestinal

Neoplasm Metastasis, Neoplasms, Colorectal Neoplasms

NCT06656598 2026-02-11

SPORADIC

152 enrolled

Phase 3 Not yet recruiting

Carcinoma, Non-Small-Cell Lung

NCT07207824 2025-10-06

HERO

182 enrolled

Genitourinary

Non-Muscle Invasive Bladder Neoplasms, Neoplasms

NCT07199855 2025-09-30

Blinatumomab Combined With Venetoclax as Maintenance Therapy After Allo-HSCT in High-risk Ph Negative Acute B-cell Lymphoblastic Leukemia

Phase 2 Active not recruiting

24 enrolled

Burkitt Lymphoma

NCT05051631 2025-08-28

BRAVE

Phase NA Completed

1,071 enrolled 11 charts

Breast

Breast Neoplasms

NCT07014202 2025-07-30

Consolidation Radiotherapy vs. Observation in Oligoresidual Advanced Non-Small Cell Lung Cancer After Chemo-Immunotherapy

224 enrolled

Phase 1 Active not recruiting

Carcinoma, Non-Small-Cell Lung

NCT07094464 2025-07-30

Maintenance Therapy With Selinexor and Azacitidine in TP53 Mutant AML/MDS After Transplantation

20 enrolled

Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT05827549 2025-06-06

ReCALL

90 enrolled

Phase 2 Not yet recruiting

Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT03690869 2025-04-08

REGN2810 in Pediatric Patients With Relapsed, Refractory Solid, or Central Nervous System (CNS) Tumors and Safety and Efficacy of REGN2810 in Combination With Radiotherapy in Pediatric Patients With Newly Diagnosed or Recurrent Glioma

Phase 1/2 Terminated

57 enrolled 31 charts

CNS

Diffuse Intrinsic Pontine Glioma, Glioma, Recurrence, Central Nervous System Neoplasms

NCT05375708 2025-03-28

SIRIUS

Phase 2 Suspended

93 enrolled

Gastrointestinal

Colorectal Neoplasms

NCT06744894 2024-12-20

SIL as Maintenance Therapy in Multiple Myeloma

50 enrolled

Phase NA Enrolling by invitation

Multiple Myeloma

NCT06714084 2024-12-03

CNCMT

20 enrolled

Gynecologic

Uterine Cervical Neoplasms

NCT06503263 2024-09-19

Zanubrutinib and Lenalidomide as Maintenance Therapy in DLBCL

240 enrolled

Lymphoma, Large B-Cell, Diffuse

NCT06341556 2024-09-04

A Multicenter, Prospective, Phase II Study of Zanubrutinib for Maintenance in Patients With Mantle Cell Lymphoma

52 enrolled

Lymphoma, Mantle-Cell

NCT06277050 2024-04-30

Maintenance Therapy With Toripalimab and Capecitabine Versus Capecitabine Alone in High-risk Nasopharyngeal Carcinoma

Phase 3 Recruiting

264 enrolled

Head & Neck

Nasopharyngeal Carcinoma

NCT02396043 2023-06-18

Modified BFM-95 Regimen as First-Line Chemotherapy in Adults With T- Lymphoblastic Lymphoma

Phase 2 Unknown

50 enrolled

Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT02063685 2022-06-21

Study to Evaluate the Efficacy of Response-adapted Strategy in Follicular Lymphoma

807 enrolled

Lymphoma, Follicular

NCT02027428 2020-08-17

Safety and Efficacy Study of Abraxane as Maintenance Treatment After Abraxane Plus Carboplatin in 1st Line Stage IIIB / IV Squamous Cell Non-small Cell Lung Cancer

427 enrolled 29 charts

Carcinoma, Non-Small-Cell Lung, Carcinoma, Squamous Cell, Lung Neoplasms

NCT01554852 2018-06-11

Myeloma XI

Phase 3 Unknown

4,420 enrolled

Multiple Myeloma, Neoplasms, Plasma Cell

NCT03489616 2018-04-05

CRAGMOLC

Phase NA Unknown

45 enrolled

Carcinoma, Non-Small-Cell Lung

NCT02919462 2018-01-16

HighTySy

Phase 2 Terminated

2 enrolled

Carcinoma, Non-Small-Cell Lung, Neoplasm Metastasis

NCT02858258 2017-12-19

ASCT After a Rituximab/Ibrutinib/Ara-c Containing iNduction in Generalized Mantle Cell Lymphoma

Phase 3 Recruiting

870 enrolled

Lymphoma, Mantle-Cell

NCT00480363 2013-07-31

QUIREDEX

120 enrolled

Smoldering Multiple Myeloma, Multiple Myeloma

NCT01665001 2012-08-17

Personalized Therapy of Precursor Lymphoid Neoplasms

Phase 2 Unknown

200 enrolled

Neoplasm, Residual, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT00560053 2008-11-27

Pethema Multiple Myeloma 2000

500 enrolled

Multiple Myeloma

NCT00599937 2008-01-24

APL93: Timing of CxT and Role of Maintenance